European Urology, Supplements, 1569-9056

Journal

More filtering options
  1. 431 INITIAL BCG INSTILLATION IS UNDER-USED IN T1 BLADDER CANCER

    S. Jahnson, D. Holmang, F. Liedberg, B. Ljungberg, P. U. Malmstrom, Wiking Månsson & H. Wijkstom, 2011, In : European Urology Supplements. 10, 2, p. 148-148

    Research output: Contribution to journalPublished meeting abstract

  2. ACUTE EFFECTS OF A NOVEL PERIPHERAL SELECTIVE CANNABINOID-2-RECEPTOR AGONIST (CANNABINOR) ON BLADDER FUNCTION IN CONSCIOUS RATS

    C. Gratzke, T. Streng, C. G. Stief, T. R. Downs, I Alroy, J. S. Rosenbaum & Petter Hedlund, 2009, In : European Urology Supplements. 8, 4, p. 271-271

    Research output: Contribution to journalPublished meeting abstract

  3. AUTOMATED IMAGE ANALYSIS CONFIRMS THE PREDICTIVE SIGNIFICANCE OF MSMB IN PROSTATE CANCER

    Anna K Dahlman, E. Rexhepaj, D. J. Brennan, W. M. Gallagher, Alexander Gaber, Anna Lindgren, Karin Jirström & Anders Bjartell, 2011, In : European Urology Supplements. 10, 2, p. 175-176

    Research output: Contribution to journalPublished meeting abstract

  4. BLADDER ELECTRICAL ACTIVITY DURING CYSTOMETRY: APPLICATION FROM RAT TO HUMAN

    T. Streng, H. Hedlund, S. Svalheim, A. Talo, C. M. Solend, K. E. Andersson & Petter Hedlund, 2009, In : European Urology Supplements. 8, 4, p. 243-243

    Research output: Contribution to journalPublished meeting abstract

  5. C-JUN INTERVENES WITH DOCETAXEL THERAPY IN CASTRATION-RESISTANT PROSTATE CANCER: AR STILL MATTERS

    Martina Tinzl, Binshen Chen, Kewei Fang, S. Y. Chen, Per-Anders Abrahamsson & Nishtman Dizeyi, 2011, In : European Urology Supplements. 10, 2, p. 294-294

    Research output: Contribution to journalPublished meeting abstract

  6. Clinical proof of concept study (blossom) shows novel beta 3 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder

    C R Chapple, O Yamaguchi, A Ridder, J Liehne, S Carl, Anders Mattiasson, M A L Arambunu, M Lucas & K Everaert, 2008, In : European Urology Supplements. 7, 3, p. 239-239

    Research output: Contribution to journalPublished meeting abstract

  7. COMPARING TESTOSTERONE AND PSA FOR DIFFERENT BASELINE TESTOSTERONE CONCENTRATIONS DURING INITIATION OF DEGARELIX AND LEUPROLIDE TREATMENT

    J. E. Damber, T. Tammela, Per-Anders Abrahamsson, P. Iversen, J. K. Jensen, T. K. Olesen & B-E Persson, 2009, In : European Urology Supplements. 8, 4, p. 130-130

    Research output: Contribution to journalPublished meeting abstract

  8. COMPLICATIONS AFTER CYSTECTOMY AND ILEAL CONDUIT FOR BLADDER CANCER IS MORE COMMON IN SMALL VOLUME HOSPITALS

    S. Jahnson, S. Holmang, F. Liedberg, B. Ljungberg, P. U. Malmstrom & Wiking Månsson, 2011, In : European Urology Supplements. 10, 2, p. 43-43

    Research output: Contribution to journalPublished meeting abstract

  9. CONTINENT CUTANEOUS DIVERSION AM LUNDIANA - COMPLICATIONS FROM RESERVOIR AND OUTLET

    Wiking Månsson, T. Davidsson, Sigurdur Gudjonsson, Fredrik Liedberg & A. Xu, 2011, In : European Urology Supplements. 10, 2, p. 325-325

    Research output: Contribution to journalPublished meeting abstract

  10. CRISP-3 AND B-MSP ON PROSTATE CANCER NEEDLE-BIOPSIES DO NOT HAVE PREDICTIVE VALUE FOR SUBSEQUENT PROSTATECTOMY OUTCOME

    A. M. Hoogland, Anna K Dahlman, C. J. Vissers, T. Wolters, F. H. Schroder, M. J. Roobol, Anders Bjartell & G. J. L. H. Van Leenders, 2011, In : European Urology Supplements. 10, 2, p. 237-238

    Research output: Contribution to journalPublished meeting abstract

  11. Cyclic AMP- and cyclic GMP-binding protein kinases in human the vagina - Expression and CO localisation with ENOS, VIP and PGP

    S Ueckert, E Waldkirch, J Sonnenberg, K Langnaese, U Jonas, G Wolf & Petter Hedlund, 2008, In : European Urology Supplements. 7, 3, p. 187-187

    Research output: Contribution to journalPublished meeting abstract

  12. CYCLIN A1 MEDIATES DRUG-RESISTANT METASTATIC SPREAD OF PCA CELLS IN XENOGRAFTS IN VIVO

    B. Wegiel, Nishtman Dizeyi, Anders Bjartell, J. Tuomela, Leszek Helczynski, Martina Tinzl, L. E. Otterbein, Per-Anders Abrahamsson, Pirkko Härkönen & Jenny L Persson, 2009, In : European Urology Supplements. 8, 4, p. 343-343

    Research output: Contribution to journalPublished meeting abstract

  13. Cytokines in urine indicates urethral origin of urgency in the "Overactive bladdersyndrome"

    O. E. Lofgren & Christer Kjellström, 2009, In : European Urology Supplements. 8, 4, p. 134-134

    Research output: Contribution to journalPublished meeting abstract

  14. Deliberate E coli 83972 bacteriuria protects against recurrent urinary tract infections

    Fredrik Sundén, 2008, In : European Urology Supplements. 7, 3, p. 267-267

    Research output: Contribution to journalPublished meeting abstract

  15. DEVELOPMENT OF A MIRNA ASSAY FOR PROSTATE CANCER DETECTION

    Olivia Larne, Anders Edsjö, Anders Bjartell & Yvonne Ceder, 2009, In : European Urology Supplements. 8, 4, p. 316-316

    Research output: Contribution to journalPublished meeting abstract

  16. DISTRIBUTION AND FUNCTION OF TRANSIENT RECEPTOR POTENTIAL ION CHANNEL A1 AND CANNABINOID RECEPTORS IN THE HUMAN PROSTATE

    C. Gratzke, P. Weinhold, O. Reich, C. G. Stief, K. E. Andersson & Petter Hedlund, 2009, In : European Urology Supplements. 8, 4, p. 190-190

    Research output: Contribution to journalPublished meeting abstract

  17. DISTRIBUTION OF THE G-PROTEIN-COUPLED RECEPTOR 55 (GPR55) IN THE RAT BLADDER AND URODYNAMIC EFFECTS OF A SELECTIVE GPR55-AGONIST IN CONSCIOUS RATS

    C. Gratzke, P. Weinhold, D. Selwood, C. G. Stief, K. E. Andersson & Petter Hedlund, 2009, In : European Urology Supplements. 8, 4, p. 271-271

    Research output: Contribution to journalPublished meeting abstract

  18. Do we need PSA and early detection of prostate cancer?

    Per-Anders Abrahamsson & Martina Tinzi, 2008, In : European Urology. Supplement. 7, 5, p. 393-395

    Research output: Contribution to journalArticle

  19. Early intravesical epirubicin instillation after transurethral resection for non-muscle invasive bladder cancer is inefficient for recurrent tumours

    Sigurdur Gudjonsson, Fredrik Liedberg, L Adell, F Merdasa, G Hagberg, R Olsson, Magnus Grabe, J Richtoff, B Larsson, Pär-Ola Bendahl & Wiking Månsson, 2008, In : European Urology Supplements. 7, 3, p. 177-177

    Research output: Contribution to journalPublished meeting abstract

  20. EFFECT OF FIBROBLAST GROWTH FACTOR 8 (FGF8B) ON VASCULARISATION AND OXYGENATION OF PC-3 PROSTATE TUMOR XENOGRAFTS

    J. M. Tuomela, T. J. Gronroos, J. A. Seppanen, M. P. Valta, J. A. Sandholm, A. J. Schrey, O. J. Eskola, O. H. Solin, H. J. Minn & Pirkko Härkönen, 2009, In : European Urology Supplements. 8, 4, p. 246-246

    Research output: Contribution to journalPublished meeting abstract

  21. Expression of cyclic AMP-dependent protein KINASE-I isoforms in the human prostate: Relation to smooth muscle alpha-actin and PDE4

    E Waldkirch, K Sigl, M Seidler, U Jonas, C G Stief, S Uecker, Petter Hedlund & E Waldkirch, 2008, In : European Urology Supplements. 7, 3, p. 95-95

    Research output: Contribution to journalPublished meeting abstract

  22. EXTENDED LYMPH NODE DISSECTION IN PATIENTS WITH UROTHELIAL CELL CARCINOMA OF THE BLADDER: CAN IT MAKE A DIFFERENCE?

    F. Liedberg, Pär-Ola Bendahl, Thomas Davidsson, Sigurdur Gudjonsson, M Holmer & Wiking Månsson, 2009, In : European Urology Supplements. 8, 4, p. 256-256

    Research output: Contribution to journalPublished meeting abstract

  23. Hormone therapy: Improving therapy decisions and monitoring

    AR Zlotta, Per-Anders Abrahamsson, B Tombal, R Berges & F Debruyne, 2006, In : European Urology. Supplement. 5, 3, p. 369-376

    Research output: Contribution to journalArticle

  24. Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

    Per-Anders Abrahamsson, 2009, In : European Urology. Supplement. 8, 11, p. 821-822

    Research output: Contribution to journalDebate/Note/Editorial

  25. Intermittent DHT administration enhances effect of docetaxel in a xenograft model by modulation of ER beta, AR and NEK2

    Martina Tinzl, Nishtman Dizeyi, Y Zhang, D Ribero, Anders Bjartell, M Marberger & Per-Anders Abrahamsson, 2008, In : European Urology Supplements. 7, 3, p. 278-278

    Research output: Contribution to journalPublished meeting abstract

  26. Learning curve of positive margin rate in laparoscopic radical prostatectomy

    F P Secin, A Cronin, J Rasseweller, J U Stolzenberg, M Hruza, C Abbou, A De La Taille, L Salomon, G Janetschek, F Nassar, I Turk, A Vanni, I Gill, J Kaock, P Koenig, L Matinez-Pinero, V Pensadoro, P Emilliozzi, Anders Bjartell, C Eden & 11 others, A Richards, R Van Vellhoven, J U Stolzenberg, R Rathemat, C Payloyich, L M So, A Levinson, C Savenge, A Vickers, K Touijer & B Guillonneau, 2008, In : European Urology Supplements. 7, 3, p. 167-167

    Research output: Contribution to journalPublished meeting abstract

  27. LONG-TERM IMPAIRED LANGUAGE AND DECREASED WELL-BEING AMONG TESTICULAR CANCER SURVIVORS WHO RECEIVED CHEMOTHERAPY - RESULTS FROM SWENOTECA

    J. Skoogh, G. Steineck, U. Stierner, Eva Cavallin-Ståhl, U. Olofsson, A. Wallin, M. Gatz & B. Johansson, 2009, In : European Urology Supplements. 8, 4, p. 358-358

    Research output: Contribution to journalPublished meeting abstract

  28. MORTALITY AMONG MEN WITH LOCALLY ADVANCED PROSTATE CANCER MANAGED WITH NON-CURATIVE INTENT; A NATIONWIDE STUDY IN PCBASE SWEDEN

    O. Akre, H. Garmo, J. Adolfsson, M. Lambe, Ola Bratt & P. Stattin, 2011, In : European Urology Supplements. 10, 2, p. 239-240

    Research output: Contribution to journalPublished meeting abstract

  29. NATION-WIDE POPULATION-BASED STUDY ON 15-YEAR MORTALITY IN PROSTATE CANCER ACCORDING TO RISK CATEGORIES IN THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN

    P. Stattin, F. Sandin, Göran Ahlgren, O. Bratt, J. E. Damber, J. Hugosson, B. Pettersson, D. Robinson, M. Tornblom, S. Karlsson, O. Andren, A. Bill-Axelson, A. Widmark, L. Egevad, Roy Ehrnström, J. Adolfsson, M. Lambe & J. E. Johansson, 2011, In : European Urology Supplements. 10, 2, p. 324-325

    Research output: Contribution to journalPublished meeting abstract

  30. Nordic observational study evaluating safety and analgesic consumption in patients with advanced cancer under zoledronic acid (ZOMETA (R)) treatment: NOSAZ-interim analysis

    Per-Anders Abrahamsson, P Ostri, M Andersen & E Kruger Hagen, 2008, In : European Urology Supplements. 7, 3, p. 232-232

    Research output: Contribution to journalPublished meeting abstract

  31. ORTHOTOPIC BLADDER SUBSTITUTES AT 12 MONTHS: WHICH IS THE BEST?

    I. Paananen, P. Ohtonen, I. Perttila, O. Jonsson, C. Edlund, P. Wiklund, B. Ljungberg, Moller K. Jensen, E. Jonsson & Wiking Månsson, 2009, In : European Urology Supplements. 8, 4, p. 301-301

    Research output: Contribution to journalPublished meeting abstract

  32. Pathophysiology of bone metastases in prostate cancer

    Per-Anders Abrahamsson, 2004, In : European Urology. Supplement. 3, 5, p. 41342

    Research output: Contribution to journalArticle

  33. Phosphodiesterase Enzymes and The Male Ejaculatory System: Expression of Pde Isoenzymes in the Seminal Vesicles

    S. Uckert, E. S. Waldkirch, Petter Hedlund & M. A. Kuczyk, 2010, In : European Urology Supplements. 9, 6, p. 639-639

    Research output: Contribution to journalPublished meeting abstract

  34. Potential benefits of muscarinic M-3 receptor selectivity

    Karl-Erik Andersson, 2002, In : European Urology. Supplement. 1, 4, p. 23-28

    Research output: Contribution to journalArticle

  35. Prostate Cancer: To Treat or Not to Treat?

    Per-Anders Abrahamsson, 2009, In : European Urology. Supplement. 8, 5, p. 418-423

    Research output: Contribution to journalArticle

  36. READMISSION AFTER RADICAL PROSTATECTOMY. NATION-WIDE, POPULATION-BASED STUDY IN PCBASE SWEDEN

    J. Fridriksson, E. Holmberg, Ola Bratt, H. Garmo, J. Adolfsson, M. Lambe, A. Bill-Axelson & P. Stattin, 2011, In : European Urology Supplements. 10, 2, p. 279-279

    Research output: Contribution to journalPublished meeting abstract

  37. Reduced risk of prostate cancer in infertile men compared to men with proven fertility: A nested case-control study

    Yasir Ruhayel, Aleksander Giwercman, Per-Anders Abrahamsson, Lars Rylander, Jonas Manjer, Göran Berglund & Yvonne Giwercman, 2008, In : European Urology Supplements. 7, 3, p. 197-197

    Research output: Contribution to journalPublished meeting abstract

  38. Revolutions in the management of hormone-refractory prostate cancer

    Per-Anders Abrahamsson, 2003, In : European Urology. Supplement. 2, 3, p. 41276

    Research output: Contribution to journalDebate/Note/Editorial

  39. SOMATOSTATIN IS EXPRESSED IN THE HUMAN PROSTATE STEM CELL NICHE AND INHIBITS EXPANSION OF LUMINAL PRECURSOR CELLS

    Jens Ceder, L Jansson, K Kjellstrom & Per-Anders Abrahamsson, 2009, In : European Urology Supplements. 8, 4, p. 248-248

    Research output: Contribution to journalPublished meeting abstract

  40. The continuing role of PSA in the detection and management of prostate cancer

    Kurt Miller, Per-Anders Abrahamsson, Koichiro Akakura, Frans M. J. Debruyne, Christopher P. Evans & Laurence Klotz, 2007, In : European Urology. Supplement. 6, 3, p. 327-333

    Research output: Contribution to journalArticle

  41. The Identification of a Novel Stromal Stem/Progenitor Cell Phenotype in the Human Adult Prostate

    Jens Ceder, Linda Jansson, Roy Ehrnström, Lars Rönnstrand & Per-Anders Abrahamsson, 2008, In : European Urology Supplements. 7, 3, p. 93

    Research output: Contribution to journalPublished meeting abstract

  42. THE P-MARK BIOBANK: A EUROPEAN MULTICENTER BIOREPOSITORY FOR PROSTATE CANCER RESEARCH

    G. L. Marsden, M. L. Goodwin, R. Kumar, C. Bangma, F. Schroder, T. Luider, Anders Bjartell, Hans Lilja, J. Schalken, F. C. Hamdy & E. Schenk, 2009, In : European Urology Supplements. 8, 4, p. 165-165

    Research output: Contribution to journalPublished meeting abstract

  43. The Prostate Cancer Prevention Trial and its implications for clinical practice: A European consensus

    Pierre Teillac & Per-Anders Abrahamsson, 2006, In : European Urology. Supplement. 5, 9, p. 640-646

    Research output: Contribution to journalArticle

  44. The role of finasteride in the management of BPH and in the prevention of prostate cancer - Introduction

    Pierre Teillac & Per-Anders Abrahamsson, 2006, In : European Urology. Supplement. 5, 9, p. 627-627

    Research output: Contribution to journalDebate/Note/Editorial

  45. THE ROLE OF HEME OXYGENASE-1 AND CARBON MONOXIDE (CO) IN REGULATION OF CHEMOTHERAPEUTIC RESPONSES IN PROSTATE CANCER

    B. Wegiel, A. Sachs, J Persson, Anders Bjartell & L. E. Otterbein, 2009, In : European Urology Supplements. 8, 4, p. 342-342

    Research output: Contribution to journalPublished meeting abstract

  46. The Roles of the Host and the Pathogens in Urinary Tract Infections

    Béla Köves & Björn Wullt, 2016 Jul 1, In : European Urology Supplements. 15, 4, p. 88-94 7 p.

    Research output: Contribution to journalArticle

  47. TRANSIENT RECEPTOR POTENTIAL A1 (TRPA1) AGONISTS DECREASE NERVE-MEDIATED RESPONSES OF THE HUMAN URETER

    P. Weinhold, Petter Hedlund, O. Reich, C. G. Stief, K. E. Andersson & C. Gratzke, 2009, In : European Urology Supplements. 8, 4, p. 206-206

    Research output: Contribution to journalPublished meeting abstract

  48. TRANSURETHRAL RESECTION OF NON-MUSCLE-INVASIVE BLADDER TRANSITIONAL CELL CANCERS WITH OR WITHOUT 5-ALA UNDER VISIBLE AND FLUORESCENT LIGHT - MULTICENTER PHASE III CLINICAL TRIAL

    M. C. Schumacher, S. Holmang, Thomas Davidsson, B. Friedrich, J. Pedersen & N. P. Wiklund, 2009, In : European Urology Supplements. 8, 4, p. 373-373

    Research output: Contribution to journalPublished meeting abstract

Previous 1 2 Next